Состояние органов репродуктивной системы у пациенток с акромегалией
Диссертация
Лечение и наблюдение за пациентками с акромегалией до настоящего времени проводилось в поликлиниках по месту жительства. Объем исследований, как правило, не включал в себя инструментальные методы. Результаты диссертационной работы внедрены в схему диагностики в клиниках эндокринологии и акушерства и гинекологии ММА им. Сеченова. Первичное обследование и динамическое наблюдение проводится… Читать ещё >
Список литературы
- Дедов И.И., Молитвословова Н. Н., Марова Е. И. Акромегалия: пособие для врачей. М., 2003.
- Иловайская И.А., Макарова H.J1. // Фарматека. 2008. — Т. 17, № 171. — С. 45−48.
- Кирющенков А.П., Хохлова И. Д., Пронин А. В. // Акушерство и гинекология. 2009. — № 1. — С. 15−20.
- Пронин B.C., Колода Д. Е., Чаплыгина Е. В. Инсулиноподобные ростовые факторы в клинической практике: биологическая роль и перспективы использования // Клиницист, № 1, 2008. с. 19
- Мельниченко Г. А., Пронин B.C., Романцова Т. И., Гурова О. Ю. с соавт. Клиника и диагностика гипоталамо-гипофизарных заболеваний. Москва, «Триада», 2005. С. 16−26.
- The Growth hormone/insulin-like growth factor axis during development. Ed by I. Varela-Nieto and J. A. Chowen/ Advances in Experimental medicine and biology. Springer, 2005. Vol 567.
- Katlas G, Androulakis I, Tziveriotis K, Papadogias D, et al. Polycystic ovaries & the policystyc ovary syndrome phenotype in women with active acromegaly// Clin End (Oxf), 2007- 67(6):917−22
- Нага M, Ichikawa K, Minemura K, Kobayashi H, Suzuki N et al. Acromegaly associated with Chiary-I malformation and polycystic ovary syndrome. Intern Med. 1996- 35(10):803−7
- Advis JP, White SS, Ojeda SR. Activation of growth hormone short loop negative feedbak delays puberty in the female rat. Endocrinology. 1981- 108:1343−1352.
- Hsu CJ, Hammond JM. Concomitant effects of growth hormone on secretion of insulin-like growth factor I and progesterone by cultured porcine gramu-losa cells. Endocrinology. 1987- 121:1343−1348
- Hennessey JV, Jackson IM. Clinical features and differential diagnosis of pituitary tumors with emphasis on acromegaly. Bailiere Clin Endocrinol Metab. 1995- 9:271−314
- Nabarro JDN. Acromegaly. Clin Endocrinol (Oxf). 1987- 26:481−512.
- Molitch ME. Pregnancy and hyperprolactinemic women. N Engl J Med. 1985- 312:1364−1370
- Sauder SE, Frager M, Case GD, Kelch RP, Marshall JC. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyper-prolactinemia and amenorrhea: resonses to bromocriptine. J Clin Endocrinol Metab. 1984- 59:941−948
- Demura R. Ono M, Demura H, Schizume DK, Oouchi H. Prolactin directly inhibits basal as well as gonadotropin-stimulated secretion of progesterone and 1713-estradiol in the human ovary. J Clin Endocrinol Metab. 1982- 54:1246−1250
- Thorner MO, Besser GM, Jones A. Bromocriptine therapy of female infertility: a report of 13 pregnancies. Br Med J. 1975- 4:694−697.
- Franks S. Polycystic ovary syndrome. N Engl J Med. 1995- 333:853−861.
- Rosenfield RL. Hyperandrogenism in prepubertal girls. Pediatr Clin North Am. 1990- 37:1333−1358.
- Low L, Chernausek S, Sperling M. Acromegaloid patients with type A insulin resistance: parallel defects in insulin and insulin growth factor-I receptors and biological responses in cultured fibroblasts. J Clin Endocrinol Metab. 1989- 69:329−337.
- Flier JS, Moller DE, Moses AC, et al. Insulin-mediated pseudoacromegaly: clinical and biochemical characterisation of a syndrome of selective insulin resistance. J Clin Endocrinol Metab. 1993- 76:1533−1541
- Barbieri RL, Smith S, Ryan KJ. The role of hyperinsulinemia in the pathogenesis of ovarian androgenism. Fertil Steril. 1988- 50:197−212.
- Kaltsas G, Mukherjee J, Jenkins P, Satta M, et al. Menstrual Irregularity in Women with Acromegaly// The Journal of Clinical Endocrinology & Metabolism. 1999- 84(8): 2731−2735
- Franks S. Polycystic ovary syndrome: a changing perspective. Clin Endocrinol (Oxf). 1989- 31:87−120.
- Moller N, Schmiotz O, Jorgensen J. Basal and insulin stimulated substrate metabolism in patients with active acromegaly before and after adenectomy. J Clin Endocrinol Metab. 1992- 74:1012−1015.
- Poretsky L, Kalin MF. The gonadotropic function of insulin. Endocr Rev. 1987- 8:132−141.
- Katz E. The potential relevance of growth hormone to female reproductive physiology and pathophysiology. Fertil Steril. 1993- 59:8—34
- Miura S, Koide S. Effect of insulin and growth hormone on rat uterine RNA synthesis. In: (3rd ed.), Proc Soc Exp Biol Med 1970- 133: 882−885
- Bezecny I, Bartova J, Skarda J. Growth hormone treatment increases oestrogen receptor concentration in the guinea-pig uterus. J Endocrinol. 1992- 135: 5−9
- Danila-Muster A, Simionescu L, Antonescu N. Participarea hormonuli so-matotrop in apartitia fibromului uterin. Cercet Endocrinol Clin, 1963- 14: 389 393.
- Spellacy W, Le Maire W, Buhi W, Birk S et al. Plasma growth hormone and estradiol levels in women with uterine myomas. Obstet Gynecol, 1972- 40:829−834
- Cohen O, Schindel В and Homburg R. Uterine leiomyomata~a feature of acromegaly. Human Reproduction, 1998- 13:1945−1946.
- Kaltsas G, Jenkins P, Webb J, Monson J et al. Uterine Leiomyomata in Women with Acromegaly. The Journal of Clinical Endocrinology & Metabolism. 2000- 85 (3): 1347.
- Fady I. Sharara, Lynnette K. Nieman. Growth hormone receptor messenger ribonucleic acid expression. American Journal of Obstetrics and Gynecology. 1995- 173 (3): 814−819
- Vollenhoven B, Herington A, Healy D. Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium. J Clin Endocrinol Metab. 1993- 76:1106−1110
- Tommola P, Pekonen F, Rutanen E. Binding of epidermal growth factor and insulin-like growth factor I in human myometrium and leiomyomata. Obstet Gynecol. 1989- 74: 658−662.
- Chandrasekhar Y, Hainer J, Osuamkpe C, Nagamani M. Insulin-like growth factor I and II binding in human myometrium and leiomyomas. Am J Obstet Gynecol, 1992- 166: 64−69.
- Giudice L, Irwin J, Dsupin В et al. Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata. Hum Reprod, 1993- 8:1796−1806.
- Moon HD, Simpson ME, Li CH, Evans HM. Neoplasms in rats treated with pituitary growth hormone. Pulmonary and lymphatic tissues. Cancer Res. 1950- 10:297−308.
- Ray BS, Pearson OH. Hypophysectomy in treatment of disseminated breast cancer. Surg Clin North Am. 1962- 12:419−433.
- Pollak MN. Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention. Breast Cancer Res Treat. 1998- 47:209−217.
- Xie SP, Pirianov G, Colston KW. Vitamin D analogues suppress IGF-I signalling and promote apoptosis in breast cancer cells. Eur J Cancer. 1999- 35:1717−1723.
- Ng ST, Zhou J, Adesanya OO, Wang J, LeRoith D, Bondy CA. Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nature. 1998−3:1141−1144.
- Yang XF, Beamer WG, Huynh H, Pollak M. Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation. Cancer Res. 1996- 56:1509−1511
- M.Shim, P. Cohen, IGFs and human cancer: implications regarding the risk of growth hormone therapy. Horm.Res. 1999: 51:42−51.
- Bengtsson BA. Acromegaly and neoplasia. J Pediatr Endocrinol. 1993- 6:73−78
- Popovic V, Damjanovic S, Micic D, et al. Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group. Clin Endocrinol (Oxf). 1998- 49:441−445
- Peyrat JP, Bonneterre J, Hecquet B, et al. Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. Eur J Cancer. 1993- 29A:492−497.
- Hankinson SE, Willett WC, Colditz GA, et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet. 1998- 351:13 931 396.
- Gunnell D, Okasha M, Smith GD, Oliver SE, et al. Height, leg length, and cancer risk: a systematic review. Epidemiol Rev 2001- 23:3134−2.
- Friedenreich CM. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 2001- 10:15−32.
- Yu H, Shu XO, Li BD, et al. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk. Cancer Epidemiol Biomarkers Prev 2003- 12:1067−73
- Lukanova A, Toniolo P, Zeleniuch-Jacquotte A, Grankvist K. Insulin-Growth factor I in pregnancy. Cancer Epidemiology Biomarkers, 2006: 15: 2489−2493.
- Isabel dos Santos Silva, Johnson N. et al. The Insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women. Cancer Epidemiology Biomarkers, 2006- 15: 449−455
- B.C. Пронин, С. Э. Агаджанян. Современные возможности медикаментозного лечения акромегалии.
- Braat D, Veersemaat S, Assiesb J, Schoemakera J. Triplet pregnancy after pulsatile gonadotrophin-releasing hormone treatment in an acromegalic woman. European Journal of Obstetrics & Gynecology and Reproductive Biology, 1994- 54:148−149.
- Luboshitzky R, Dickstein G, Barzilai D. Bromocriptine-induced pregnancy in an acromegalic patient. JAMA. 1980- 244(6):584−6.
- Davidoff LM. Hyperpituitarism and hypopituitarism. Bull NY Acad Med. 1940- 16:227.
- Eriksson L, Frankenne F, Eden S, Hennen G, von Schoultz B. Growth hormone 24-hour serum profiles during pregnancy-lack of pulsatility for the secretion of the placental variant. Br J Obstet Gynecol. 1989- 96:949−953
- Beckers A, Stevenaert A, Foidart J-M, et al. Placental and pituitary growth hormone secretion during pregnancy in acromegalic women. J Clin Endocrinol Metab. 1990- 71:725
- Wilson DM, Bennett A, Adamson GD, et al. Somatomedins in pregnancy: a cross-sectional study of insulin-like growth factors I and II and somatomedin peptide content in normal human pregnancies. J Clin Endocrinol Metab. 1982- 55:858−869.
- Berelowitz M, and HowGo E. Non-insulin diabetes mellitus secondary to other endocrine disorders. In: LeRoith D, Taylor SI, Olefsky JM eds. Diabetesmellitus. A fundamental and clinical text. New York: Lippincott-Raven, 1996- 496−502.
- Cozzi R, Attanasio R, Barausse M. Pregnancy in acromegaly: a one-center experience. Eur J Endocrinol. 2006- 155(2):279−84.
- Molitch ME. Pregnancy and hyperprolactinemic women. N Engl J Med. 1985- 312:1364−1370.
- Krupp P, Monka C, Richter K. The safety aspects of infertility treatments. Proc of the 2nd World Congr of Gynecol and Obstet. 1988- 9.
- Raymond JP, Goldstein E. Konopka P, Leleu MF, et al. Follow-up of children born of bromocriptine-treated mothers. Horm Res., 1985- 22:239−246
- Bigazzi M, Ronga R, Lacranjan I, et al. A pregnancy in an acromegalic woman during bromocriptine treatment: effects on growth hormone and prolactin in the maternal, fetal and amniotic compartments. J Clin Endocrinol Metab. 1979- 48:9
- Montini M, Pagani G, Gianola D, Pagani MD, et al. Acromegaly and primary amenorrhea: Ovaluation and pregnancy induced by SMS 201−995 and bromocriptine Letter. J Endocrinol Invest. 1990- 13:193
- Mozas J, Ocon E, Lopezdela Torre M, Suarez A. Successful pregnancy in a woman with acromegaly treated with somatostatin analog (octreotide) prior to surgical resection. International Journal of Gynecology &Obstetrics, 1999- 65:71−73.
- Fassnacht M, Capeller B, Arlt W, Steck T, et al. Octreotide LAR treatment throughout pregnancy in an acromegalic woman. Clin Endocrinol (Oxf). 2001- 55(3):411−5.
- Menis E, Billeci D, Marton E. Uneventful Pregnancy in an Acromegalic Patient Treated with Slow-Release Lanreotide: A Case Report. The Journal of Clinical Endocrinology & Metabolism, 1999- 84(4): 1489
- Dreval A., Pokramovich J., Nechaeva O. Pregnancy and childbirth in active acromegaly patient treated with long acting somatostatin analogue.// European Congress of Endocrinology 2009. Istanbul, Turkey. 25 April 2009 29 April 2009, 20P175.
- Brian SR, Bidlingmaier M, Wajnrajch MP, Weinzimer SA, et al. Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects. J Clin Endocrinol Metab. 2007- 92(9):3374−7
- Brodsky JB, Cohen EN, Brown Jr BW et al. Surgery during pregnancy and fetal outcome. Am J Obstet Gynecol. 1980- 138−1165.
- Magyar DM, Marshall JR. Pituitary tumors and pregnancy. Am J Obstet Gynecol. 1978- 132:739−751
- Gonzalez J, Elizondo G, Saldivar D, Nanez H, et al. Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. Am J Med. 1988- 85:217−220
- Scheithauer BW, Sano T, Kovacs KT, et al. The pituitary gland in pregnancy: a clinicopathopathologic and immunohistochemical study of 69 cases. Mayo ClinProc., 1990- 65:461.
- Stefaneau L, Kovacs K, Lloyd RV, et al. Pituitary lactotrophs and somatotrophs in pregnancy: a correlative in situ hybridization and immunohistochemical study. Virch Arch Cell Pathol. 1992- 62:291−296.
- Lunardi P, Rizzo A, Missori P, Fraioli B. Pituitary apoplexy in an acromegalic woman operated on during pregnancy by transphenoidal approach. Int J Gynaecol Obstet. 1991- 34(l):71−4.
- Kupersmith M- Rosenberg C, Kleinberg D. Visual Loss in Pregnant Women with Pituitary Adenomas. Annals of Internal Medicine. 1994- 121 (7): 473−477
- Herman-Bonert V, Seliverstov M, Melmed S. Pregnancy in Acromegaly: Successful Therapeutic Outcome. The Journal of Clinical Endocrinology & Metabolism, 1998- 83(3): 727−731
- O’Herlihy C. Pregnancy in an acromegalic after bromocriptine therapy. Ir J Med Sci. 1980- 149(7):281−2
- Yamashita Y, Namimoto T, Abe Y, et al. MR imaging of the fetus by a HASTE sequence. Am J Roentgenol. 1997- 168:513−519
- Wass J. Acromegaly: treatment after 100 years. BMJ, 1993- 307: 15 051 506
- Bates AS, van’t Hoff W, Jones JM, Clayton RN. An audit of outcome of treatment in acromegaly. Quarterly Journal of Medicine 1993- 86: 293—299.
- Orme SM, McNally RJ, Cartwright RA & Belchetz PE. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. Journal of Clinical Endocrinology and Metabolism 1998- 83: 2730−2734.
- Holdaway IM, Rajasoorya RC & Gamble G. Factors influencing mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism 2004- 89: 667−674.
- Stewart P. Acromegaly databases time for European unification. European Journal of Endocrinology, 2004- 151: 431−432
- Wass JH, Carson MN, Bates PR. The changing patterns of presentation and treatment of acromegaly in the UK reflected by the UK National Acromegaly Database. Endocrine Abstracts 2004- 7 PI25.
- Пронин B.C., Молитвословова H.H. Акромегалия. Этиология, патогенез, клиника, диагностика лечение /Под ред. Акад РАН и РАМН И. И. Дедова, член-корр. РАМН Г. А. Мельниченко. М., Корпорация «Я», 2009.
- Di Chiro G., Nelson K.B. The volume of the sella turcica//Am. J. Radiol. 1962. V. 87. P. 989−1008.
- Образовательный Мастер-курс по артериальной гипертонии и сердечно-сосудистому риску Москва, 12−13 сентября 2007 г. Эпидемиология артериальной гипертонии.
- Manual of Endocrinology & Metabolism. Edit. Norman Lavin. Lippincott Willams&Wilkins, 2002- c. 396.
- Клиническая эндокринология. Под ред. Старковой Н. Т. СПб, Питер, 2002- с. 213.
- Ю1.Вейн A.M., Елигулашвили T.C. Особенности синдрома апноэ во сне в неврологической клинике // Журнал невропатологии и психиатрии имени С. С. Корсакова. 1992.- №. 2.- С. 66−69.
- Дедов И.И., Мельниченко Г. А., Романцова Т. И. Синдром гиперпро-лактинемии. М.-Тверь, Триада-Х, 2004- с. 126.
- Внутренние болезни, под ред. Харрисона Т. Р. Пер с англ. М, Медицина, 1996- с. 43.
- Зыкин Б.И. Ультразвуковая диагностика в гинекологии: Атлас. М: Видар, 1994. С. 29.
- Вихляева Е. М. Климактерический синдром и его лечение М, 1966
- Буланов М. Н. Ультразвуковая диагностика в гинекологической практике. М.- 2002.
- Демидов В.Н., Гус А.И. Ультразвуковая диагностика гиперпластических и опухолевых процессов эндометрия В книге: Клиническое руководство по ультразвуковой диагностике // Под ред. Митькова В. В., Медведева М. В. Т. 3. М.: Видар, 1997.
- Терегулова JI.E. // Ультразвуковая диагностика. 1996. N4. С. 21−23-
- Well D, Yang Н, Houseni М, Iruvuri S, et al. Age-Related Structural and Metabolic Changes in the Pelvic Reproductive End Organs. Seminars in Nuclear Medicine, Volume 37, Issue 3, May 2007, Pages 173−184
- Oppermann K, Fuchs SC, Spritzer PM. Ovarian volume in pre- and perime-nopausal women: a population-based study. Menopause, 2003 May-Jun-10(3):209−13.
- Wallace W, Kelsey T. Ovarian reserve and reproductive age may be determined from measurement of ovarian volume by transvaginal sonography. Human Reproduction, Vol. 19, No. 7, 1612−1617, July 2004
- Стрижаков A.H., Давыдов А. И. Клиническая трансвагинальная эхография. М., 1997
- Aleem F.A., Zeitoun К., Calame R. et al. Ultrasound Obstet Gynecol 1995−4:304−309.
- Кондриков Н.И. Структурно-функциональные изменения эндометрия под воздействием стероидных гормонов. Практ. гинек. 1999- 1(1): 20−5.
- Простая гиперплазия эндометрия. Оценка пролиферативной активности по уровню Ki-67. R.A. Ambros. Int J Gyn Path, 19:206−211, 2000
- Merce LT, Lopez Garcia G, de la Fuente F. Doppler ultrasound assessment of endometrial pathology. Acta Obstet Gynecol Scand. 1991- 70(7−8):525−30.
- Кирющенков А. П, Мельниченко Г. А., Хохлова И. Д., Пронин А. В., Семенов Н. С., Гигель. ЕЛ, Пронин B.C. Состояние репродуктивной системы у пациенток с акромегалией. // Акушерство и гинекология. -2009. № 4. — С. 33−37
- Коколина В.Ф. Детская и подростковая гинекология. М., Медпракти-ка-М, 2006.-с. 300−301.
- Бесплодный брак. Современные подходы к диагностике и лечению. / Под ред. В. И. Кулакова. М.: Гэотар-Медиа, 2006. — С. 126−128
- Мельниченко ГА, Соснова Е. С., Романцова ТЛ, Пивоварова С. В., Жукова Э. В. Восстановление репродуктивной функции при шперпролакганемическом гипогонадиз-ме// Акушерствои гинекология.-2001. -№ 3.-с. 36−39
- Вихляева Е.М. О стратегии и тактике ведения больных с миомой матки / Вестник Российской ассоциации акушеров-гинекологов.-1997.-№ 3.-С.21−23.
- Вихляева Е.М., Василевская JI.H. Миома матки. М.:"Медицина", 1981-
- Aleem F. Pennisi J. Zeitoun К. Predanic M. The role of color Doppler in diagnosis of endometriomas // Ultrasound Obstet Gynecol. 1995 Jan. 5(1). 51−4-
- Jonatan S. Berek. Novak’s gynecology в пер. M, «Практика», 2002 с. 668
- Сидоренко JI.M. Мастопатия. Л., 1991
- Швецова О.Б. // Гинекология. 2000. — Т.2, № 5. — с. 43−46
- Joerger AC, Fersht AR. Structural biology of the tumor suppressor p53. Annu Rev Biochem. 2008- 77:557−82.
- Karp JE, Broder S. Molecular foundations of cancer: new targets for intervention. Nat Med. 1995 Apr-l (4):309−20.
- Федорова E.B., Побединский H.M., Хохлова И. Д., Липман А. Д. Цветовое допплеровское картирование и допплерометрия артерий миометрия и эндометрия. / Ультразвуковая диагностика. 2000. — № 1.-е. 52−64
- Мельниченко Г. А., Пронин B.C., Колода Д. Е., Гитель Е. П. и др. Место аналогов соматостатина в комбинированной лечении синдрома избыточной продукции гормона роста. М., «Фирма Печатный двор», 2008. С. 61